355 related articles for article (PubMed ID: 2939141)
1. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
2. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
Pesando JM; Graf L; Hoffman P
J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
4. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
6. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
Guy K; Docherty LJ; Dewar AE
Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
[TBL] [Abstract][Full Text] [Related]
7. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
8. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.
Gonwa TA; Frost JP; Karr RW
J Immunol; 1986 Jul; 137(2):519-24. PubMed ID: 3088102
[TBL] [Abstract][Full Text] [Related]
9. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
10. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
11. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
13. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
Momburg F; Koretz K; Von Herbay A; Möller P
Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
[TBL] [Abstract][Full Text] [Related]
14. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
15. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
16. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
17. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet B-induced loss of HLA class II antigen expression on lymphocytes is dose, time, and locus dependent.
Deeg HJ; Sigaroudinia M
Exp Hematol; 1990 Sep; 18(8):916-9. PubMed ID: 2387342
[TBL] [Abstract][Full Text] [Related]
19. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
[TBL] [Abstract][Full Text] [Related]
20. Malignant human B cells express two populations of p24 surface antigens.
Pesando JM; Hoffman P; Conrad T
J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
